Anand Reddi is Adverum’s vice president, head of corporate strategy and external affairs & engagement. He is responsible for leading Adverum’s corporate strategy, investor relations, corporate communications, patient advocacy, public affairs, global market access and government affairs & policy. He also serves as Chief of Staff.
Mr. Reddi joins Adverum from Gilead Sciences Inc., where he most recently served as head of digital innovation, customer engagement, global commercial strategy and operations. In this role, he led the design, implementation, and launch of PrEP Hub™, a direct-to-consumer (DTC) digital navigator platform for individuals at risk for HIV. At Gilead, Mr. Reddi also held various strategy and operations roles of increasing responsibility in international access, medical affairs, international operations, corporate affairs, corporate strategy, global commercial product strategy and in the chief patient officer organization focused on patient centricity, digital patient solutions and patient centered outcomes. He was instrumental in establishing international access and emerging markets initiatives in over 140 countries for the HIV medicines Truvada®, Descovy®, Genvoya® and Biktarvy® and the hepatitis C treatments Sovaldi®, Harvoni®, Epclusa® and Vosevi® resulting in over 18 million patients with access to these treatments in resource limited settings.
Prior to Gilead, Mr. Reddi was active in basic science, clinical research and global health policy with over 20 peer reviewed publications. His basic science research focused on skin cancer metastasis and signal transduction as well as bone tissue engineering. His clinical research and public health interests focused on global HIV/AIDS. His writings on global health have appeared in scientific journals such as Science, JAMA Pediatrics, AIDS, and JAIDS as well as in the opinion pages of The Huffington Post (as a featured contributor), The Washington Post and The New York Times.
Mr. Reddi was a Doctor of Medicine candidate and holds a Master of Science from the University of Colorado School of Medicine. He received a Bachelor of Arts in history and a Bachelor of Science in biology from the University of Michigan, Ann Arbor. In addition, Mr. Reddi has the distinction of serving as a J. William Fulbright Scholar in South Africa. Mr. Reddi also served as vice-chair on the board of directors of the Bay Area Global Health Alliance and past member of the board of directors of the AIDS Healthcare Foundation. In 2016, he was an Atlantic Dialogues Emerging Leader.